Natural History Study of Patients with Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency

Active, not recruitingOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

May 31, 2029

Study Completion Date

June 30, 2029

Conditions
Succinic Semialdehyde Dehydrogenase Deficiency
Interventions
DEVICE

Transcranial magnetic stimulation (TMS)

Transcranial magnetic stimulation (TMS) is a method for noninvasive electrical cortical stimulation, where small intracranial currents are generated by a powerful, fluctuating, extracranial magnetic field. TMS is unique in its capacity for experimental, diagnostic, and therapeutic utility. Single pulse (spTMS) and paired-pulse TMS (ppTMS) have been used extensively to study, measure, and modulate cortical excitability and plasticity.

DEVICE

Magnetic resonance imaging (MRI)

These will be outpatient MRI studies that are planned without sedation. Subjects enrolled at BCH will undergo brain MRI, including volumetric MRI, MRS, and diffusion tensor imaging (DTI). The data will help define the natural history of brain volume, brain myelination and spectroscopic (e.g. GABA) abnormalities.

DEVICE

Electroencephalogram (EEG)

These will be outpatient EEG recordings that span 20-60 minutes and done without sedation. Recordings will be performed using electrode locations specified by the international 10-20 system for standard clinical practice.

PROCEDURE

Bio-specimen Collection

Bio-specimen collection will include blood, urine, saliva, hair, stool, and a skin biopsy. Blood, urine, saliva, blood spots, and hair samples will also be banked for to-be-determined (TBD) studies.

Trial Locations (4)

02115

Boston Children's Hospital, Boston

Unknown

University Children's Hospital, Heidelberg

Sant Joan de Deu Hospital Barcelona, Barcelona

Birmingham Children's Hospital NHS Foundation Trust, Birmingham

All Listed Sponsors
collaborator

Washington State University

OTHER

collaborator

University of South Florida

OTHER

collaborator

University Hospital Heidelberg

OTHER

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Boston Children's Hospital

OTHER

NCT03758521 - Natural History Study of Patients with Succinic Semialdehyde Dehydrogenase (SSADH) Deficiency | Biotech Hunter | Biotech Hunter